tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Technical Analysis

Compare
1,829 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Traws Pharma’s (TRAW) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Traws Pharma is a Sell.
Traws Pharma’s (TRAW) 20-Day exponential moving average is 7.19, while Traws Pharma’s (TRAW) share price is $7.67, making it a Buy.
Traws Pharma’s (TRAW) 50-Day exponential moving average is 6.93, while Traws Pharma’s (TRAW) share price is $7.67, making it a Buy.

Traws Pharma (TRAW) Pivot Points

Feb 05, 2025, 07:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.64
6.81
7.05
7.22
7.46
7.63
7.87
Fibonacci
6.81
6.97
7.07
7.22
7.38
7.48
7.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Traws Pharma (TRAW) Moving Averages

Feb 05, 2025, 07:48 AM
Period
Simple
Exponential
MA5
7.36Buy
7.28Buy
MA10
6.82Buy
7.16Buy
MA20
7.25Buy
7.19Buy
MA50
6.63Buy
6.93Buy
MA100
6.23Buy
7.35Buy
MA200
9.32Sell
10.40Sell
Traws Pharma’s (TRAW) 10-Day exponential moving average is 7.16, while Traws Pharma’s (TRAW) share price is $7.67, making it a Buy.
Traws Pharma’s (TRAW) 100-Day exponential moving average is 7.35, while Traws Pharma’s (TRAW) share price is $7.67, making it a Buy.
Traws Pharma’s (TRAW) stock price is $7.67 and Traws Pharma’s (TRAW) 50-day simple moving average is 6.63, creating a Buy signal.
Traws Pharma’s (TRAW) stock price is $7.67 and Traws Pharma’s (TRAW) 100-day simple moving average is 6.23, creating a Buy signal.
Traws Pharma’s (TRAW) stock price is $7.67 and Traws Pharma’s (TRAW) 200-day simple moving average is 9.32, creating a Sell signal.

Traws Pharma (TRAW) Technical Indicators

Feb 05, 2025, 07:48 AM
Name
Value
Implied Action
RSI (14)
52.95
Neutral
STOCH (9,6)
87.07
Sell
STOCHRSI (14)
62.56
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
29.52
Neutral
Williams %R
-7.66
Sell
CCI (14)
5.00
Neutral
ATR (14)
1.01
-
Ultimate Oscillator
60.98
Neutral
ROC
2.18
Buy
Traws Pharma’s (TRAW) Relative Strength Index (RSI) is 52.95, creating a Neutral signal.
Traws Pharma’s (TRAW) Trend Strength Indicator (ADX) is 29.52, creating a Neutral signal.
Traws Pharma’s (TRAW) Commodity Channel Index (CCI) is 5.00, creating a Neutral signal.
Traws Pharma’s (TRAW) Price Rate of Change (ROC) is 2.18, creating a Buy signal.

FAQ

Is TRAW a Buy, Hold, or Sell?
Based on TRAW’s technical indicators, TRAW is a Buy.
    What is TRAW’s RSI (14)?
    TRAW’s RSI (14) is 52.95, which suggests TRAW is a Neutral.
      What is TRAW’s MACD?
      TRAW’s MACD is <0.01, which suggests TRAW is a Sell.
        What is TRAW’s 5-day moving average?
        TRAW’s 5-day moving average is 7.36, which suggests TRAW is a Buy.
          What is TRAW’s 20-day moving average?
          TRAW 20-day moving average is 7.25, which suggests TRAW is a Buy.
            What is TRAW’s 50-day moving average?
            TRAW’s 50-day moving average is 6.63, which suggests TRAW is a Buy.
              What is TRAW’s 200-day moving average?
              TRAW’s 200-day moving average is 9.32, which suggests TRAW is a Sell.
                What is TRAW’s Williams % R (14)?
                TRAW’s Williams % R (14) is -7.66, which suggests TRAW is a Sell.
                  What is TRAW’s CCI (14)?
                  TRAW’s CCI (14) is 5.00, which suggests TRAW is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis